Edge restenosis has gained attention as a main cause of restenosis after first-generation drug-eluting stent (DES) implantation. The aim of this study was to assess the incidence of edge restenosis and identify the predictors of edge restenosis after second-generation DES implantation. Data were obtained from several postmarketing surveillance (PMS) studies on a cobalt-chromium everolimus-eluting stent (CoCr-EES; Xience V/ PROMUS, Xience Prime, Xience Prime SV, and Xience Expedition SV), a second-generation DES, in Japan. Angiographic analysis was conducted at the baseline and after eight months on the following subsegments: instent region, proximal edge, and distal edge. Restenosis was defined as !50% diameter stenosis (DS) at followup. We used multivariate logistic regression (with lesions as a random effect) to compare the instances of restenosis between the proximal and the distal edges. Univariate and multivariate analyses of the risk factors for restenosis were performed for each subsegment. We analyzed 1,966 lesions in 1,687 patients. The restenosis rates at the in-stent region, proximal edge, and distal edge were 4.4%, 3.0%, and 1.1%, respectively. The risk of restenosis at the distal edge was significantly lower than that at the proximal edge, when adjusted for 13 variables. The predictors of restenosis were postprocedural % diameter stenosis (%DS), postprocedural reference diameter, !45°bending, stent overlap at the proximal edge, and postprocedural %DS at the distal edge. Our analysis of eight-month angiographic outcomes from CoCr-EES PMS demonstrated that postprocedural %DS is a major predictor of edge restenosis. Edge restenosis is more likely attributable to postprocedural angiographic results than to the patient's background.
D espite advances in interventional technologies, restenosis of the segments adjacent to the proximal and distal edges of first-generation drugeluting stents (DESs), such as the sirolimus-eluting stent (SES), has been reported. 1, 2) The mechanism of edge restenosis has been indicated as a result of arterial injury to the adjacent area by the stent deployment balloon, 3) inappropriate coverage of the plaque as in longitudinal geographic miss, 4) balloon-artery size mismatches as in axial geographic miss, 4, 5) and mechanical stresses, such as the stresses created by severe angulation at the edge of the stent as well as bulky struts 6) with a bare metal stent or first-generation DESs. Although second-generation DESs, the current first-line coronary stents, have thinner struts, no meticulous analysis of edge restenosis following their implantation has yet been conducted, except for a report on target lesion revascularization at edges. 7) The aim of this study, therefore, was to investigate the incidence of and predictors for angiographic edge restenosis after second-generation DES implantation by means of qualitative and quantitative angiographic analyses of the cobaltchromium everolimus-eluting stent (CoCr-EES) using realworld data from CoCr-EES postmarketing surveillance (PMS) Japan.
Methods

Population and study design: CoCr-EES PMS Japan is a
From the 1 Department of Biostatistics, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2 Division of Cardiology, Teikyo University School of Medicine, Tokyo, Japan, 3 Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan, 4 Division of Cardiology, National Hospital Organization Osaka National Hospital, Osaka, Japan, 5 Cardiovascular Center, Nagoya Daini Red Cross Hospital, Nagoya, Japan, ANGIOGRAPHIC EDGE RESTENOSIS OF 2ND-GENERATION DES multicenter registry that enrolls patients who have undergone CoCr-EES (Xience V/PROMUS, Xience Prime, Xience Prime SV, or Xience Expedition SV; Abbott Vascular, Abbott Park, IL, USA) implantation in order to evaluate the safety and efficacy of this device in a realworld setting in Japan. The details of part of this program, Xience V/PROMUS PMS, have been described previously. 8) Angiographic follow-up was mandated eight months after stent implantation in these registries. Quantitative coronary angiography was performed before and after stenting and at follow-up in each of the following subsegments: proximal edge, distal edge, in-stent region, and in-segment region. An edge was defined as the area 5 mm from the stent edge. The in-segment region included the in-stent region as well as the proximal and distal edges. Early follow-up angiograms for target vessel revascularization were included in the analysis, except for those conducted because of stent thrombosis within 30 days. We excluded patients who had no baseline information or angiographic data (either procedural or follow-up). In cases of missing data for the proximal edge or in-stent regions at follow-up due to total occlusion, postprocedural angiograms were regarded as missing data. Cases of unsuccessful implantation (in-segment !50% diameter stenosis, DS) after stent implantation or thrombus in myocardial infarction flow grade 0 and 1 were also excluded.
Preprocedural patient preparations were performed according to each healthcare facility's standard of care for interventional cardiology, and the treatment strategy was managed by the participating physicians. The postprocedural antiplatelet therapy was left to the discretion of each cardiologist at the participating study sites. Data collection and management: Clinical and procedural information was collected at the participating sites using electronic or paper case report forms. Angiographic data were collected by Abbot Vascular Japan (Tokyo, Japan) and analyzed at an independent core laboratory (Cardiocore Japan, Tokyo, Japan) with QCA-CMS (Medis Medical Imaging Systems B.V., Leiden, the Netherlands) version 6 (Xience V/Promus) or version 7.1 (Xience Prime, Xience Prime SV, and Xience Expedition SV) using a validated automated edge-detection algorithm. 9) The use of the data in this study was approved by the research ethics committee of the University of Tokyo [Examination No. 11459-(2) ].
Statistical analyses:
The primary endpoint of this study was the incidence of restenosis. In this study, restenosis was defined using angiography as %DS !50% for each subsegment at an eight-month follow-up.
We confirmed whether the probability of restenosis between the proximal and distal edges was different before investigating for restenosis in each segment. In order to do this, we used logistic regression models with random intercepts that accounted for the clustered nature of characteristics within lesions remaining after multivariate adjustment. The lesion-level variance, which is estimated as the variance in normally distributed random intercepts, was translated to a median odds ratio (OR): the median ORs of the higher-risk lesion to the lower-risk lesion over the random sampling of two lesions from the study population. 10) The logistic model included 14 variables, which have been indicated as risk factors for in-stent restenosis from previous research, as follows: %DS, postprocedural reference diameter (RD), absolute difference in diameter between the stent and vessel, !45°bending within the insegment region, stent overlap, hypertension, previous coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), insulin-treated diabetes, dyslipidemia, hemodialysis, severe or moderate calcification, age, and gender. The model was fitted through maximum likelihood with an adaptive Gauss-Hermite quadrature method using SAS/GLIMMIX version 9.4 (SAS Institute, Cary, NC, USA).
Furthermore, the risk factors in each subsegment were examined by univariate and multivariate analyses of the aforementioned 14 variables. The univariate analysis for in-stent restenosis was performed using 13 variables because it was impossible to calculate the absolute differ-KOZUMA, ET AL ence in diameter between the stent and vessel for the instent region. The multivariate analysis model for in-stent restenosis was also constructed using these 13 variables. Statistical analyses were also performed using SAS/ GLIMMIX. A two-sided P-value of < 0.05 was considered statistically significant.
Results
The patient selection process is shown in Figure 1 in Japan. The average age of the analyzed patients was 68 ± 10 (mean ± standard deviation) years. The prevalence of diabetes and hemodialysis in this group was 41.8% and 3.2%, respectively. The majority of PCIs were performed for stable ischemic heart diseases. The prevalence of type B2/C lesions was 81.7%. On average, nontarget patients were significantly older and had a lower body mass index. A greater proportion of nontarget patients had diabetes mellitus and renal insufficiency and had had a prior cere-brovascular accident. Nontarget lesions demonstrated severe or moderate calcification and tortuosity. The relationship between potential risk factors and DS at follow-up was graphically reviewed (Figures 2-4) . The box plots show that the tortuous curvature did not increase %DS at follow-up. The scatter plot of %DS before the procedure and during the follow-up shows a linear association, although the difference between the stent size and postprocedural edge RD did not affect edge %DS at ANGIOGRAPHIC EDGE RESTENOSIS OF 2ND-GENERATION DES follow-up. Table III presents the angiographic results for each subsegment (i.e., proximal edge, distal edge, in-stent region, and in-segment region). The average reference vessel diameter was 2.8 ± 0.6 mm, and the average lesion length was 18.3 ± 12.0 mm. After stenting, %DS was smaller at the in-stent region compared with the edges. The difference in %DS between the in-stent region and the edges was slightly smaller at follow-up when compared with after stenting. Of 144 restenosis lesions, the restenosis pattern classified by Mehran as focal, diffuse, occlusive, and proliferative was 91 (63.2%), 30 (20.8%), 17 (11.8%), and 6 (4.2%) lesions, respectively. The estimated OR of restenosis between the proximal and distal edges adjusted by the logistic regression model is shown in Table IV. The model showed a significantly lower probability of restenosis at the distal edge compared to the proximal edge (OR: 0.19, 95% confidence interval [CI]: 0.09-0.37; P < 0.001).
The predictors of restenosis for each subsegment are shown in Figures 5-7 . Postprocedural %DS, postprocedural RD, stent overlap, insulin-treated diabetes, previous PCI, and hemodialysis were identified as predictors for instent restenosis. At the proximal edge, postprocedural % DS, postprocedural RD, !45°bending (negative relationship), and stent overlap were significant independent predictors. At the distal edge, postprocedural %DS was the only significant predictor of restenosis.
Discussion
This real-world multicenter PMS study in Japan demonstrated that (1) the angiographic restenosis rates at the proximal and distal edges eight months after CoCr-EES implantation were 3.0% and 1.1%, respectively, whereas the restenosis rate in the in-stent region was 4.4%; (2) there was no evidence of mechanical stress, such as axial geographic miss or curvature of the stented lesion, affecting edge restenosis; and (3) %DS following stent implantation was the main independent predictor of edge restenosis.
The mechanism of edge restenosis has been reported in several studies, which demonstrated a combination of neointimal hyperplasia and negative remodeling adjacent to the stent edge using QCA and IVUS. 3, 11) In the firstgeneration DES era, several studies on SES implantations reported higher incidences of edge versus in-stent restenosis. In the SIRIUS study (a multicenter, randomized, double-blind trial of the SIRolImUS-coated Bx-Velocity stent in the treatment of patients with de novo coronary artery lesions), restenosis was observed at the in-stent region (3.2%) and at the proximal (5.5%) and distal (2.0%) edges. 12) With regard to the edge restenosis of secondgeneration DESs, a subanalysis of the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET) study reported that proximal and distal edge restenosis of EES occurred at a rate of 1.1% and 0.7%, respectively. 13) However, the study comprised a relatively small number of patients because of its randomized design. The present study is the first to report the rates of restenosis in a real-world setting at each subsegment region (i.e., the in-stent region, as well as the proximal and distal edges) after the implantation of CoCr-EES, a second-generation DES. Further, we assessed more than 1,000 lesions by means of core lab QCA.
Plaque burden at the stent edge has been reported as an important predictor of stent edge restenosis. 14) Complete (normal-to-normal) coverage had been suggested during stent implantation since the era of bare metal stents. 3, 4, [15] [16] [17] [18] The determination of the adequate stent landing zone, using imaging modalities such as IVUS or optical coherence tomography, was suggested for better clinical outcomes of PCIs. 16, 19, 20) Angiographic restenosis has KOZUMA, ET AL Figure 5 . Estimates of the predictors for restenosis (in-stent). CABG indicates coronary artery bypass grafting; CI, confidence interval; OR, odds ratio; PCI, percutaneous coronary intervention; RD, reference diameter; and %DS, % diameter stenosis. been reduced by the full coverage of plaque using IVUS. 5, 18) It is important to note that an increase in edge residual stenosis led to an increase in the chance of restenosis in this study. Full coverage of the lesions by a postprocedural stent is essential for good outcomes, even in this era of second-generation DESs. Multivariate analysis of each segment also demonstrated that edge restenosis might be attributed to angiographic results after the procedure rather than to the patient's background, such as insulin-treated diabetes, hypertension, dyslipidemia, hemodialysis, age, and gender. The low median OR (2.43) in a comparison analysis between the edges supports this observation. Prediction of edge restenosis by angiographic parameters could be useful for the reduction of the cost of PCIs.
This study demonstrated, using a model adjusted for 13 variables, that the risk of restenosis after stenting is lower at the distal edge compared to the proximal edge. These findings are in accordance with the results of previous studies on first-generation DESs. 1, 21, 22) One study showed a higher drug concentration at the distal edge, 23) which may explain the lower risk of restenosis. In this regard, careful attention should be paid to cover proximal, rather than distal, plaque at the time of coronary stent positioning. However, a significant lumen reduction at the distal edge was observed two years after EES implanta-ANGIOGRAPHIC EDGE RESTENOSIS OF 2ND-GENERATION DES Figure 6 . Estimates of the predictors for restenosis (proximal). CABG indicates coronary artery bypass grafting; CI, confidence interval; OR, odds ratio; PCI, percutaneous coronary intervention; RD, reference diameter; %DS, % diameter stenosis; and |Stent diff|, absolute difference between stent size and RD. tion in the SPIRT2 trial. 24) Further investigation to assess the long-term edge effect is required.
Implantation of a metallic stent induces a compliance mismatch between the native artery and the stent. This modifies the distribution of shear stress because of a change in the three-dimensional vessel geometry, 25, 26) especially at the curvature adjacent to the stent edges. The flexibility of all newer-generation DESs has improved. 6) Similarly, axial geographic miss, defined as a diameter mismatch between the stent and the native arteries, may also induce mechanical stress to the wall, resulting in edge restenosis with DES. 4, 5) However, axial geographic miss had a minimal influence on the outcomes of first-generation DESs in the STTLR study (a multicenter prospective study of SES). 16) These mechanical stresses may be caused by thicker struts and might be associated with a risk of angiographic and clinical restenosis. 27, 28) Selection of newer devices has been recommended on account of thinner struts and better flexibility compared to first-generation DESs. 6) The present study demonstrated that a nontortuous curvature was a predictor of restenosis at the proximal edge. However, it is difficult to explain the mechanism behind this finding. The avoidance of edge stress may be attributable to the EES strut (89 μm), which is thinner than the struts on the first-generation SES (152 μm).
KOZUMA, ET AL Figure 7 . Estimates of the predictors for restenosis (distal). CABG indicates coronary artery bypass grafting; CI, confidence interval; OR, odds ratio; PCI, percutaneous coronary intervention; RD, reference diameter; %DS, % diameter stenosis; and |Stent diff|, absolute difference between the stent size and RD.
Limitations: There are some limitations to this study. First, lesions without follow-up angiography were excluded from the analysis. Since patients with complex conditions tend to avoid follow-up angiograms, selection bias cannot be ruled out. Second, even though this is one of the largest angiographic studies examining the restenotic response of second-generation DESs, the incidence of restenosis was too low to demonstrate the clinical impact of residual stenosis at the edges of the stent. Third, in the present study, we used angiographic data analyzed using two versions of QCA: CMS version 6.3 and version 7.1. However, the measurements of the minimum diameter and RD were not different between these two versions. 29) 
Conclusions
Multivariate analysis of eight-month angiographic outcomes from this CoCr-EES PMS study demonstrated a higher restenosis risk in proximal than in distal edges. Postprocedural %DS can be regarded as a main predictor for edge restenosis in the real-world setting. Edge restenosis might be attributed to angiographic results after the procedure rather than to the patient's background, such as insulin-treated diabetes, hypertension, dyslipidemia, hemodialysis, age, and gender.
